Colgate Palmolive India's shares hit a 52-week low after weak Q1FY26 results. Volume decline, urban slowdown, and high costs dent margins. Analysts slash EPS forecasts, recovery seen only in H2FY26.

UBS lowered its price target on Colgate-Palmolive (NYSE: CL) to $106 from $109 while maintaining a Buy rating, citing valuation discipline following the stock’s steady run in recent months.

Colgate-Palmolive India Ltd reports 11.9% decline in net profit due to subdued urban demand and competition.

Colgate Palmolive India reported a decline in first-quarter profit on Tuesday, as feeble urban demand and intensified competition in its core oral care business weighed on sales.

Colgate Palmolive Q1 results 2025: The company reported a 11.8 per cent year-on-year (YoY) decline in its net profit to ₹321 crore, as compared to ₹364 crore for the same period last year.

Fast-Moving Consumer Goods (FMCG) major Colgate Ltd will accelerate premiuimisation through innovation and bring in global personal and home care offerings to India. In its annual report, the ...

Colgate-Palmolive covers all expenses associated with Colgate Women’s Games, allowing athletes to participate – and their families and friends to attend – at no cost.

At the Indian Digital Media Awards (IDMA) 2025, Colgate-Palmolive (India) Limited made a big impression by taking home one gold, two silver, and one bronze for their tech-driven and purpose-driven ...

Colgate Palmolive (India) Ltd. was trading at Rs 2,283.60, a 4.03% decline in Wednesday's session, making it one of the top losers on the Nifty Midcap 150.

Colgate-Palmolive spends Rs 188.41 crore on advertising in Q1 FY2026 The FMCG major reported an 11.8% year-on-year (YoY) decline in net profit, falling to Rs 320.62 crore from Rs 363.98 crore in ...

Sharekhan is bullish on Colgate Palmolive India has recommended buy rating on the stock with a target price of Rs 2687 in its research report dated July 22, 2025.